In situ cancer vaccination with a replication-conditional HSV for the treatment of liver metastasis of colon cancer (Q77666270)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857031%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

In situ cancer vaccination with a replication-conditional HSV for the treatment of liver metastasis of colon cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857031%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

1 reference

Takashi Endo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857031%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Masahiro Toda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857031%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Masahiko Watanabe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857031%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Yukihiko Iizuka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857031%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Tetsuro Kubota

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857031%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Masaki Kitajima

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857031%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Yutaka Kawakami

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857031%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 February 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857031%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857031%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857031%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857031%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

142-148

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857031%20AND%20SRC:MED&resulttype=core&format=json

Diagnostic evaluation and survival analysis of colorectal cancer patients with liver metastases

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

Surgical treatment of liver metastases in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

Factors influencing the natural history of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

Factor(s) present in herpes simplex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: characterization of an ICP6 deletion mutant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type 1 (G207).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

G207, modified herpes simplex virus type 1, kills human pancreatic cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

Immune response against tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

Intravesical and intravenous therapy of human bladder cancer by the herpes vector G207

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700407

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700407

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857031%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857031%20AND%20SRC:MED&resulttype=core&format=json